459 related articles for article (PubMed ID: 18560297)
21. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.
Ingram JR; Martin JA; Finlay AY
Am J Clin Dermatol; 2009; 10(4):229-37. PubMed ID: 19489656
[TBL] [Abstract][Full Text] [Related]
22. Measurement of quality of life in atopic dermatitis: correlation and validation of two different methods.
Herd RM; Tidman MJ; Ruta DA; Hunter JA
Br J Dermatol; 1997 Apr; 136(4):502-7. PubMed ID: 9155948
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a new moisturizer (Exomega milk) in children with atopic dermatitis.
Giordano-Labadie F; Cambazard F; Guillet G; Combemale P; Mengeaud V
J Dermatolog Treat; 2006; 17(2):78-81. PubMed ID: 16766330
[TBL] [Abstract][Full Text] [Related]
24. The course of life of patients with childhood atopic dermatitis.
Brenninkmeijer EE; Legierse CM; Sillevis Smitt JH; Last BF; Grootenhuis MA; Bos JD
Pediatr Dermatol; 2009; 26(1):14-22. PubMed ID: 19250399
[TBL] [Abstract][Full Text] [Related]
25. A study of targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD).
Shaw M; Morrell DS; Goldsmith LA
Pediatr Dermatol; 2008; 25(1):19-24. PubMed ID: 18304147
[TBL] [Abstract][Full Text] [Related]
26. Social impact of atopic dermatitis.
Lapidus CS; Kerr PE
Med Health R I; 2001 Sep; 84(9):294-5. PubMed ID: 11565277
[TBL] [Abstract][Full Text] [Related]
27. Atopic dermatitis and alternative management strategies.
Anderson PC; Dinulos JG
Curr Opin Pediatr; 2009 Feb; 21(1):131-8. PubMed ID: 19242250
[TBL] [Abstract][Full Text] [Related]
28. Childhood Atopic Dermatitis Impact Scale: reliability, discriminative and concurrent validity, and responsiveness.
Chamlin SL; Lai JS; Cella D; Frieden IJ; Williams ML; Mancini AJ; Chren MM
Arch Dermatol; 2007 Jun; 143(6):768-72. PubMed ID: 17576944
[TBL] [Abstract][Full Text] [Related]
29. Impact of canine atopic dermatitis on the health-related quality of life of affected dogs and quality of life of their owners.
Linek M; Favrot C
Vet Dermatol; 2010 Oct; 21(5):456-62. PubMed ID: 20492625
[TBL] [Abstract][Full Text] [Related]
30. Impairment quality of life in families of children with atopic dermatitis.
Al Robaee AA; Shahzad M
Acta Dermatovenerol Croat; 2010; 18(4):243-7. PubMed ID: 21251439
[TBL] [Abstract][Full Text] [Related]
31. Development of a questionnaire to assess the impact of atopic dermatitis on health-related quality of life of affected dogs and their owners.
Favrot C; Linek M; Mueller R; Zini E;
Vet Dermatol; 2010 Feb; 21(1):63-9. PubMed ID: 20187912
[TBL] [Abstract][Full Text] [Related]
32. Pediatric health-related quality of life questionnaires in clinical trials.
Raat H; Mohangoo AD; Grootenhuis MA
Curr Opin Allergy Clin Immunol; 2006 Jun; 6(3):180-5. PubMed ID: 16670511
[TBL] [Abstract][Full Text] [Related]
33. Quality of life in atopic dermatitis patients.
Mozaffari H; Pourpak Z; Pourseyed S; Farhoodi A; Aghamohammadi A; Movahadi M; Gharaghozloo M; Moin M
J Microbiol Immunol Infect; 2007 Jun; 40(3):260-4. PubMed ID: 17639168
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of the impairment of quality of life in Czech children with atopic dermatitis of different age groups and their families.
Jiráková A; Vojáčková N; Göpfertová D; Hercogová J
Int J Dermatol; 2012 Jun; 51(6):688-92. PubMed ID: 22607286
[TBL] [Abstract][Full Text] [Related]
35. An international multicenter study on quality of life and family quality of life in children with atopic dermatitis.
Chernyshov PV; Jirakova A; Ho RC; Moed H; Caldeira AP; Alvarenga TM; Park CW; Hercogova J
Indian J Dermatol Venereol Leprol; 2013; 79(1):52-8. PubMed ID: 23254729
[TBL] [Abstract][Full Text] [Related]
36. [Quality of life in patients with atopic dermatitis: using the Japanese version of the SF-36 health status questionnaire].
Fukuroku K; Nagano T; Ogino S
Arerugi; 2002 Dec; 51(12):1159-69. PubMed ID: 12522320
[TBL] [Abstract][Full Text] [Related]
37. [Observational study to evaluate the impact of an educational/informative intervention in the emotional status (anxiety) of patients with atopic dermatitis (CUIDA-DEL)].
Guerra-Tapia A; Lleonart M; Balañá M
Actas Dermosifiliogr; 2007 May; 98(4):250-8. PubMed ID: 17506956
[TBL] [Abstract][Full Text] [Related]
38. Belgian observational drug utilization study of pimecrolimus cream 1% in routine daily practice in atopic dermatitis.
De Backer M; Morren MA; Boonen H; Boyden B; Vertruyen A; Lecomte P; Paquay C; Lesaffre E; Lambert J
Dermatology; 2008; 217(2):156-63. PubMed ID: 18525202
[TBL] [Abstract][Full Text] [Related]
39. Family functioning and illness perception of parents of children with atopic dermatitis, living without skin symptoms, but with psychosomatic symptoms.
Rodríguez-Orozco AR; Kanán-Cedeño EG; Guillén Martínez E; Campos Garibay MJ
Iran J Allergy Asthma Immunol; 2011 Mar; 10(1):61-5. PubMed ID: 21358017
[TBL] [Abstract][Full Text] [Related]
40. The development of a preference-based measure of health in children with atopic dermatitis.
Stevens KJ; Brazier JE; McKenna SP; Doward LC; Cork MJ
Br J Dermatol; 2005 Aug; 153(2):372-7. PubMed ID: 16086752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
